Pharmacy chains activity analysis

Pharmacy chains activity analysis

Russian pharmaceuticals retail chain segment evaluation, both on the level of the state and in particular regions. Pharmacy chains development forecast

Forecasting

Product sales and separate market development forecast, based on unique mathematical models

Business and marketing plan development

Development of detailed business-plans, required to evaluate the reasonability of project start

Search of partners for contract production in Russia

Potential partners search and evaluation, based on their technical opportunities, appropriate experience, and reputation

Monitoring of import substitution

assessment of the main trends of import substitution policies and localization processes in the pharmaceutical market in Russia, the key beneficiaries and companies at risk

Latest news

4/3/2020 Database Update: Import of Veterinary Drugs, Feed Supplements, and Veterinary APIs to Russia (February 2020)

Between January and February 2020, Russia imported 2.46 bln RUB worth of veterinary drugs (customs clearance prices), which is monetary terms (rubles) 37% lower than that of the same period in 2019. The import volume of feed supplements amounted to 4.35 bln RUB, with the dynamics of -20%. As for veterinary APIs, the import volume is 306 mln RUB, and the dynamics are -14%.

4/2/2020 Database Update: API Import to Russia (February 2020)

Between January and February 2020, Russia imported 22.6 bln RUB worth of APIs (customs clearance prices, VAT included), which is in monetary terms (rubles) 18.5% higher than that of the same period in 2019. The dynamics in physical terms are +31%, with 2.2 thousand tons of APIs.

4/1/2020 Database Update: Pharmaceutical Drug Import to Russia (February 2020)

Between January and February 2020, Russia imported 27 bln RUB worth of ready-made pharmaceuticals (customs clearance prices), which is in monetary terms (rubles) 65% lower than that of the same period in 2019. The import volume of the first two months of 2020 turned out to be lower than that of any January, when the activity of the importers is usually the lowest. The dynamics of the in-bulk import in monetary terms are +28%, with the volume of 22.5 bln RUB.

3/31/2020 Survey by RNC Pharma and Doktor Na Rabote (Doctor at Work): 66% of Doctors Believe that Devaluation of the Ruble will Decrease Healthcare Availability

Only 5% of Russian doctors believe that the devaluation of the ruble will not change anything in the Russian pharmaceutical market, according to an online survey by the RNC Pharma analyst company and the Doktor Na Rabote (Doctor at Work) social media service for doctors. Another 2% expect that prices rises will decrease demand for “useless” drugs (vitamins, probiotics, etc.).

3/26/2020 Veterinary Vaccine Import to Russia in 2019

Vaccines were the most imported veterinary product in 2019, accounting for 45% of the total import in monetary terms, which has not changed much in recent years. In 2019, Russia imported 16.9 bln RUB worth of veterinary vaccines (customs clearance prices), which is in monetary terms (rubles) 37.4% higher than that in 2018. The dynamics are high, but far from record-worthy, as there has been three better results in the last 10 years. The dynamics in physical terms (units) are +43.8%, with 9.4 bln units.

All news [168]

Our competences

RNC Pharma is focused on providing information about development trends of Russian pharmaceutical market infrastructure component. Our experts also provide services on strategic marketing, such as forecasting, business planning, etc.